Infection Control Market Analysis and Reports | Canada Conference Series

Market Analysis - Infection Control 2018

Importance and Scope

Infection control refers to policies and procedures used to minimize the risk of spreading infections, especially in hospitals and human or animal health care facilities. The purpose of infection control is to reduce the occurrence of infectious diseases. These diseases are usually caused by bacteria or viruses and can be spread by human to human contact, animal to human contact, human contact with an infected surface, airborne transmission through tiny droplets of infectious agents suspended in the air, and finally by such common vehicles as food or water.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Conferenceseries LLC welcomes all the specialists and super specialists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Infection Control-2018. It also catalyses for information exchange and networking between researchers and business entrepreneurs of diverse backgrounds for the advancement of Technology and Research in the field of Infection Control. As this will be the best amalgamation of academia and research involving every aspect of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

With the grand success from the previous relevant annual International conferences, Conference Series LLC is organizing “Infection Control” (Infection Control 2018) scheduled during September 17-18, 2018 in San Diego, USA. Infection Control 2018 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.

Who should attend?

•           Microbiologists

•           Bacteriologists

•           Virologists

•           Parasitologists

•           Mycologists

•           Pathologists

•           Pharmacists

•           Epidemiologists

•           Health Care Professionals

•           Infectious Diseases Specialists

•           Infection Prevention and Infection Control Specialists

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

•              Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

•              Infectious Diseases Researchers, Scientists, Faculties, Students

•              Infectious Diseases Associations and Societies

•              Medical Colleges

•              Pharmaceutical Companies and Industries

•              Medical Devices Manufacturing Companies

•              Drug Manufacturing Companies and Industries

•              Laboratory Technicians and Diagnostic Companies

•              Business Entrepreneurs and Industrialists

•              Training Institutes

•              Software Developing Companies

•              Data Management Companies

A Unique Opportunity for Advertisers and Sponsors at this International event: http://infectioncontrol.conferenceseries.com/sponsors.php

 

Infection Control Global Market

Global infection control market is expected to witness profitable growth opportunities over the forecast period owing to factors such as increasing geriatric population, rising population of chronic diseases and increasing number of surgical infections.  Furthermore, infections caused due to pathogenic bacteria, viruses, fungi, and parasites, transmission of pathogens through interactions between two people are the major factors driving the market, or from a hospital worker to a patient and maintenance of unhygienic conditions in health care centres. Several bacteria, viruses and parasites cause infections and infectious diseases. The scientists identify most of these infection triggers. However, infectious diseases are one of the major causes behind overall deaths across the globe for the past several years. This shows the need for powerful infection control methods for long-term relief, protection and prevention from different types of infections. Infection control is a vast discipline, which deals with various nosocomial infections. These infections are associated with healthcare related signs and symptoms.

Infection control measures are performed to preserve people, who are suffering from various infections in general as well as while receiving medical treatment due to their health problems. Also, infection control refers to the discipline regarding the prevention of nosocomial infections (hospital-acquired infections). First line infection control measures include hand washing before coming in touch with patients since hand becomes the first contact path for micro-organisms.

Infection Control Market by Sterilization & Disinfection Products

Global infection control market is divided on the basis of product and end user, which includes products for disinfection and sterilization procedures. Disinfection product segment is taken in to consideration for the largest share of infection control market in 2014. This product segment contains disinfectants, disinfectors, medical nonwoven products, UV disinfectors and endoscopic equipment such as reprocessors. During the forecast period, Endoscopic equipment and UV disinfectors are the fastest growing product segments. Growing importance of diagnostic and therapeutic(endoscopic procedures) , followed by increasing demand for minimally invasive surgeries are some of the major factors attributing to market growth. Technological advancements pertaining to replacement of unsafe chlorine based disinfection equipment is an emerging trend gearing up the adoption of UV disinfectors over the coming years. The sterilization products market consists of sterilization methods and contract sterilization. On the basis of end users the market is segmented into hospitals, medical device companies, lifesciences companies, food industry, pharmaceutical companies, and other end users.

The disinfection products counted for the largest share of the infection control market in 2015. In the healthcare industry the large share of the disinfection market can be assigned to the large-scale use of disinfectors and medical nonwovens. However, the sterilization products market is expected to grow at a higher CAGR during the forecast period due to growing values on infection control policies within hospital surroundings and strengthening of government regulations for quality of healthcare services delivered.

Global Infection Control Market, by Region

1.      Middle East and Africa
2.      Asia-Pacific
           ·         China
           ·         India
           ·         Japan
           ·         Rest of Asia-Pacific (RoAPAC)
3.      North America
           ·         Canada
           ·         U.S.
4.   Europe
            ·         Italy
            ·         Spain
            ·         Germany
            ·         France
            ·         U.K.
            ·         Rest of Europe (RoE)
5. Latin America
            ·         Mexico
            ·         Brazil
            ·         Rest of Latin America

This analysis is a process of direct information, quantitative and qualitative assessment by industry analysts, inputs from industry experts and participants across the value chain. The report provides complete analysis of parent market trends, governing factors and macro-economic indicators along with market attractiveness as per divisions. The report also shows the qualitative impact of various market factors on market segments and geographies.

Scope of Infection Control Market and Future Trends

The market for infection control is expected to show high growth rate during the upcoming period owing to rising incidences of hospital-acquired infectious diseases. It has been estimated in U.S. Department of Health and Human Services, that one in every 20 infections is hospital-acquired diseases in the U.S. In various nations such as U.S., Japan and U.K there is a improvement of reimbursement scenario regarding infection control. It will further drive the growth of infection control market. Likewise, aging population will also increase the growth of infection control market. It has been estimated that the global elderly population is expected to reach around 2 billion by 2050 which was around 524 million in 2010 by the World Health Organization (WHO).

In hospitals rising number of surgeries will also support the growth of infection control market. It has been around 48 million surgical procedures were performed in the U.S estimated by. alone in 2009. In addition, rising rate of various diseases like cancer and tuberculosis, will also increase the growth of infection control market. Around 8.7 million people suffered from tuberculosis (TB) and around 1.4 million died due to the disease in 2011 estimated by WHO. The growth of infection control market  undoubtedly driven by these all parameters. The major players of infection control market operating includes Steris Corporation, Johnson and Johnson, Belimed AG, CISA Group, Getinge Group, Kimberly-Clark Corporation, Cantel Medical Corporation, Nordion, Inc. and Synergy Health plc among other significant players.

In infection control market Future market trend shows the increased growth and demands for e-beam and gamma sterilization services. These type of services are likely to take over the Et O sterilization process. This is the effect of wide application area of both gamma and e-beam sterilization. For the sterilization of cosmetics, food, medical devices, pharmaceutical devices and life science devices both these methods are useful. Sanitation and cleaning are some other major services in the infection control market along with disinfection and sterilization,.

According to the studies, Hand hygiene is now regarded as one of the most important element of infection control activities which is least accepted. Hand sanitization market is fast growing with good hope for growth. In the near future these are all the factors make the infection control market, a flourishing market with expectations of growth and profit.

 Companies Covered

3M COMPANY

BELIMED

CANTEL MEDICAL

CROSSTEX INTERNATIONAL

ETHOX CORPORATION

EVOQUA WATER TECHNOLOGIES

GE HEALTHCARE

GENE THERAPY SYSTEMS INC

NELSON LABORATORIES INC

NOVIRA THERAPEUTICS INC

PANASONIC BIOMEDICAL

PALMERO HEALTHCARE

TOTALCARE

TUTTNAUER

Johnson & Johnson

Novarties

Infection Control-2018 will be the best platform for all the specialists and super specialists, renowned Scientists, research scholars, students from leading universities and research institutions making this event as a remarkable conference to share experience, foster collaboration across industry and academia, and evaluate emerging technologies across the globe.